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Introduction
Deafness is one of the most common otologic diseases
and a major disease that greatly impacts the Chinese pop-
ulation. From the Second National Sample Survey of
Disabled Persons, it is estimated that there are 27,800,
000 hearing disabled persons in China, about 2.14% of
the population. Hearing disability continues to increase
at a rate of 30,000 hearing impaired newborns per year
and is at the top of the six major disabilities. In the clinic,
different types of hearing loss are treated differently
based upon our understanding of their pathogenic mecha-
nisms and hearing-speech loss characteristics, but the
recently noticed auditory neuropathy (AN) lacks thor-
ough research and standard effective management [1].
AN is a clinically unique disease characterized by deteri-
oration of temporal processing and intact outer hair cell
(OHC) functions [2-4]. From the literature, AN may account
for up to 10% of cases of severe or profound hearing
loss [5]. Studies have shown that lesions in AN may involve
inner hair cells (IHCs), synapses and auditory nerve
trunk, but the main challenge now is the lack of clear
localizing diagnosis which leads to uncertainties in its
intervention [6].
Discovery and naming of AN
In the 1980s, a few researchers noticed ABR waves
and thresholds that were not explainable by pure tone
audiometric results in a small number of patients. For
example, Worthington et al reported 4 cases with reason-
able audiograms but no ABRs or significantly inappropri-
ate ABR thresholds [7]. Krause et al reported 7 cases in
which audiometry showed normal hearing or moderate
hearing loss with no history of brainstem injury, but
ABR waves III and V were missing [8]. These cases gen-
erated little interests at the time.
In 1991, Starr et al [2] reported one case in which
ABRs were missing with moderate low frequency hear-
ing loss, deteriorated speech discrimination and absent
acoustic reflex, but normal CM and OAEs. Psychophysi-
cal studies showed impaired timing cue perception but
unaffected intensity and frequency cue perceptions. The
authors believed that the lesion locations in such cases
might include the auditory nerve, synapses, IHCs and, to
a small degree, OHCs. In 1992, GU Rui et al reported
16 cases of bilateral sensorineural hearing loss with un-
matched speech discrimination and pure tone thresholds,
and absent or abnormal ABRs. Except for the two cases
in which cerebral atrophy or brainstem tumor were be-
lieved to the underlying etiology, there was no evidence
of neurological pathologies in the rest 14 cases [9]. Starr
et al conducted follow up studies on similar cases and re-
ported 10 cases of seemingly intact cochlear function but
deteriorated temporal auditory processing in 1996. In 8
of these cases (80% ), there was evidence of auditory
nerve pathology [1]. Based on these works, Starr et al be-
lieved that the pathological process in these patients was
similar to that in peripheral sensory neuropathy, includ-
ing loss of afferent nerve fibers, demyelination and par-
tial demyelination in surviving nerve fibers, and for the
first time proposed the concept of AN in describing this
group of patients [1]. The term fitted well in the clinical
observations at the time.
Increasing clinical evidence has shown that, among
patients diagnosed with AN, the rate of accompanying
neurological pathologies is significantly lower than that
in Starr’s initial report [5]. Researchers have later real-
ized that lesion sites in these patients are not limited to
the auditory nerve, but lesions at IHCs, synapses and the
auditory nerve trunk can all lead to symptoms in AN and
hair cells and synapses are probably more likely to be in-
volved. This adds increased controversy in the naming
of this type of disease. Rapin and Gravel believe that,
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unless there is evidence of auditory nerve damage, the
term "auditory neuropathy" may not be appropriate.
They propose the use of a broader definition of "nerve
conduction disease" [10]. Others have proposed using the
double meaning term "auditory neuropathy/auditory
dys-synchronization (or AN/AD)" [4, 11]. At the Internal
Conference on Diagnosis and Intervention of Auditory
Neuropathy in Italy in 2008, a guide line for differential
diagnosis and intervention of AN in children was pro-
posed, which named this class of diseases as"auditory
neuropathy spectrum disorder"(or ANSD) [12, 13]. The two
mainstream terms at this time are AN and ANSD. In
consideration of its broad use in the clinic, AN is used in
this report to refer to the condition in this group of pa-
tients.
Epidemiology and etiology of AN
Summarized in Table 1 are epidemiology reports regard-
ing AN in the literature. It shows that the rate of AN is
about 7% to 13.4% (average 10%) among children with
confirmed diagnosis of severe or profound hearing loss [5,
14-19], with a matched gender ratio [19, 20]. When the average
hearing screened newborn population is used, the rate
falls blow 1% [17, 20]. Among all age populations or
deaf-mute school students, average rate of AN is below
3% [21-24]. These data show that AN rate decreases as
patient age increases. From this, it is speculated that AN
may be a condition related to hereditary and/or peri-natal
factors and may be present in about 10% of high risk
children. It may be diagnosed at newborn times and
should be suspected in children failing hearing screening
or deemed at high risk.
Etiologies leading to AN clinical presentations may in-
clude neonatal hyperbilirubinemia, degenerative neural
diseases, metabolic neural diseases, hereditary motor
neuron diseases, demyelination diseases, inflammatory
neural diseases, ischemic/hypoxic neuropathy, cerebral
edema, cerebral palsy, abnormal release of neurotrans-
mitters, infectious diseases (e.g. parotiditis), autoim-
mune diseases and development retardation. From the
latest literature, neonatal hyperbilirubinemia and hypox-
ia are the most important risk factors [18]. Gene mutation
is another major cause for some AN phenotypes, espe-
cially in AN children with non-syndromic pre-lingual
deafness.
AN clinical audiology characteristics and
diagnosis
Currently, reported clinical characteristics vary greatly
among AN patients. Clinically, compromise of auditory
nerve activities are represented by abnormal or absent
ABRs, absence or elevated thresholds in acoustic reflex
with absent or weak contralateral inhibition, etc. Cochle-
ar function indicators such as otoacoustic emissions
(OAEs) and cochlear microphonic (CM) are usually nor-
mal. There are also unique psychophysical presentations.
Clinical complaints or functional hearing loss in AN
patients are reflected mainly through psychophysical
Year
1999
2002
2005
2006
2008
2009
2010
2009
2006
2009
2006
2004
2007
2001
Authors
Rance et al [20]
Siniger et al [26]
Cheng et al [21]
Foerst et al [23]
Vlastarakos et al [24]
Sanyelbhaa [7]
Berlin et al [8]
Dowley et al [27]
Foerst et al [23]
Dowley et al [27]
Kumar et al [29]
Tang et al [30]
Lotfi et al [31]
Lee et al [32]
Study Subjects
Children with severe or profound hearing loss
Patients in NIDCD sponsored newborn hearing screening
Students in US deaf and mute schools
Children with severe SNHL
Children with confirmed hearing loss
Children with severe or profound hearing loss
Children with hearing loss
Children with severe SNHL
Average newborns
Average newborns
Adult SNHL patients
Students in HK deaf and mute schools
Students in deaf and mute schools
Students in deaf and mute schools
AN/Total n
1/9
Review
76/777
32/379
Meta-analysis
15/112
Review
12/30
32/3415
12/45050
1/183
3/123
13/841
2/81
Prevalence (%)
11.100
10.00
9.78
8.44
8.00
13.40
>10.00
40.00
0.94
0.03
0.55
2.44
1.55
2.50
Table 1. AN Prevalence in Literature Reports
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testing. Because psychophysical testing requires cooper-
ation by the patient, its results are available only from
older children and adults. Among AN patients reported
in the literature, pure tone hearing loss ranges from mild
to profound, although mild and moderate in most cases.
Audiogram patterns are also variable, although dominat-
ed by ascending patterns [25]. Speech discrimination dis-
orders are the most difficult for AN patients, typically
showing unproportionally poor discrimination contrasted
to pure tone thresholds, especially in noise [4, 26]. Middle
ear muscle reflex and olivocochlear reflex are important
to hearing in noise. These are compromised in AN pa-
tients, i.e. loss of efferent inhibition. This may explain
the poor speech discrimination in noise. Zeng et al
found that AN patients had decreased sensitivity to tem-
poral envelop fluctuation and speculated that speech dis-
crimination difficulties in AN patients might be related
to compromised temporal processing [3]. Compromised
timing cue perception may affect low frequency discrimi-
nation, temporal separation perception, timing integra-
tion, temporal modulation perception, forward and back-
ward masking, signal recognition in noise, binaural beat,
interaural temporal difference based sound localization,
etc. On the other hand, intensity cue perception, such as
intensity discrimination and interaural intensity differ-
ence based sound localization, is no different in AN pa-
tients from normal individuals [27].
Among existing diagnostic criteria for AN, the only
widely accepted mandatory one is "absent or abnormal
ABRs", which represents disruption to synchronicity in
activities along the auditory pathway. All patients includ-
ed in AN studies so far show this presentation. Abnor-
mal ABRs in AN usually refer to inappropriate ABR
morphology or thresholds not anticipated based upon
pure tone thresholds. This is probably the most distinct
clinical feature in AN. Another necessary presentation is
"intact OHC function", as represented by existence of
OAEs or CM or both. It is widely accepted that OAEs
originate from OHCs, but whether CM is solely from
OHCs or may contain contributions from IHCs is still
being debated. Because of this, when OAEs are not pres-
ent, CM may not be the definite indication of "intact
OHC function". Some believe that the linearity of CM
input/output (I/O) curve reflects the presence of OHCs
[28] and that perfect linearity represents loss of OHC
compression functions and only contributions from
IHCs. On the other hand, non-linearity in CM I/O
curves indicates intact OHC function, although this does
not necessarily provide information on IHCs. Used togeth-
er with ABR results, OAEs can be an important indicator
of AN. However, linearity measurement has not been
quantified and its relations with OHC function have not
been confirmed by laboratory or clinical data, leaving
rooms for debate over if AN can be diagnosed based on
CM linearity data.
Simultaneous presence of the two indicators discussed
above is a necessary requirement (inclusion criteria) for
differentiation from other sensorineural hearing loss and
diagnosis of AN. Almost all AN subjects in the reported
literature have been identified using these two condi-
tions [5]. Combined testing of ABRs, CM and OAEs pro-
vides information regarding diseases locations along the
auditory pathways including OHCs, auditory nerve and
brainstem, although there still lacks means to identify
diseases at IHCs and pre- or post-synaptic locations.
Electrophysiological characteristics of AN
The CM, summiting potential (SP), compound action
potential (CAP) and central auditory evoked potentials
(CAEPs) in AN patients all have distinct features that
can be used to differentiate sub-types of AN and facili-
tate clinical diagnosis and intervention.
Starr [29] and Santarelli [30] found that click induced CM
in AN children is abnormally large in amplitude. SHI
Wei et al [28] concluded that non-linearity in CM I/O
curve indicates intact OHCs but is insufficient to deter-
mine the status of IHCs.
Round window electrocochleography (RW ECoG) us-
es transtympanic electrode to record cochlear responses
and provides increased details in information regarding
the cochlea and VIIIth cranial nerve. Studying the SP
and AP in RW ECoG in conjunction with observation of
abnormal positive potential (APP) [30] or dentritic poten-
tial (DP) [31] may help locating the AN disease site.
O'Leary et al were the first to report SP with delayed
latencies and increased amplitudes (i.e. APP) on RW
ECoG in some children with profound hearing loss [32].
Santarelli [30] and McMahon et al [31] later also recorded
APP in some AN children. Santarelli divided RW ECoG
findings in AN patients into three groups: 1) presence of
both SP and CAP, indicating postsynaptic lesions at prox-
imal auditory nerve endings; 2) presence of SP with
absence of CAP, indicating pre-synaptic lesions at IHCs;
and 3) increased SP amplitude with delayed latencies (or
APP) and no CAP, representing pre-synaptic lesions, per-
haps from compromised neurotransmitter release pro-
cess [30]. McMahon et al [31] believed that APP represent-
ed pre-synaptic damage, but the mechanisms may be
similar to that causing increased SP amplitude in pa-
tients with endolymphatic hydrops (i.e. bias shift of IHC
cilia toward an "off" position). In their study, SP latency
was normal, followed by a long negative potential, in
some AN patients, which was considered as a DP indicat-
ing post-synaptic damage. In general, presence of APP
appears to indicate pre-synaptic damage or damage to
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the sensory cells, whereas obvious DP may indicate
post-synaptic damage or damage to the auditory nerve.
Therefore, RW ECoG wave analysis may help formulating
audiological intervention strategies for AN patients. The
14 AN children in McMahon's report all received cochlear
implant [31]. Electrically evoked ABR (EABR) waves were
poorly differentiated in children with SP + DP, showing
that neural synchronization was not improved by electrical
stimulation. EABRs, however, were normal in children
withAPP. Gibson and Sanli[33] reported similar findings.
Auditory evoked potentials originating from the thala-
mus and cerebral cortex may provide hearing capabili-
ties in AN patients. The P1-N1-P2 components in
CAEPs arise from primary auditory cortex in the trans-
verse temporal gyrus. The important CAEP mismatch
negativity (MMN) comes from the planum temporale
outside the auditory cortex and from the lateral posterior
temporal gyrus and can be viewed as an indicator of
pre-cortical hearing discrimination. MMN in AN chil-
dren indicates retained coding of auditory information at
a cortical level. Such CAEP testing may provide objec-
tive means in evaluating auditory threshold and speech
discrimination capability in AN patients, especially in
children who are unable to cooperate or use hearing aids
or cochlear implants. Current research data support the
notion that presence of CAEPs (including MMN) is cor-
related to speech discrimination in AN children. Rance
et al [34] reported CAEP testing in 18 AN patients, show-
ing that normal CAEPs were correlated to better speech
discrimination than those with poor CAEPs. Speech dis-
crimination scores in AN children with positive MMN al-
so seem to be superior over those without. Pearce et al
[35] applied CAEP testing in 2 infants diagnosed with AN.
Hearing aids were chosen for the one with positive
CAEPs and cochlear implant for the one in whom
CAEPs could not be induced with or without assistance.
Despite the above mentioned electrophysiology tests,
the sensitivity and specificity of these tests remain to be
further studied for hopefully their utility as an objective
means in evaluating hearing and speech discrimination
capability in young AN children and in predicting inter-
vention outcomes.
Pathophysiological mechanisms of AN
Possible lesion sites in AN include IHCs, IHC ribbon
synapses and auditory nerve trunk. Damage at these lo-
cations may lead to two neurophysiology consequences
[27]: 1) loss of synchronization of neural discharges from
auditory nerve demyelination and/or synaptic dysfunc-
tion between the auditory nerve and IHCs; and 2) de-
crease in neural discharges due to loss of receptors or ax-
ons (Figure 1).
The accuracy of auditory temporal coding is main-
tained by multiple physiological mechanisms. IHCs are
the cells that provide sound information to the central
nervous system. Each IHC synapses with multiple inde-
pendent afferent nerve fibers and each synapse is able to
release glutamate to activate rapid depolarization. Gluta-
mate released in the process quickly opens the post-syn-
aptic AMPA glutamate receptor. The excitatory post-syn-
aptic currents (EPSCs) at the nerve ending show rapid
rising and falling, allowing fast repetitive discharges in
short time. Similar nerve sizes mean similar transduc-
tion velocity, leading to optimal synchronization in dis-
charges. As it approaches the node of Ranvier, signal
conduction assumes a saltatory (jumping) pattern, great-
ly increasing the speed of conduction. Under normal cir-
cumstances, all nerve fibers fire in a very short period of
time with in a very coherent manner. If neurotransmitter
release is disrupted by IHC lesions, or if the number or
sensitivity of receptors is compromised by synaptic le-
sions, or if conduction velocity is impeded by nerve fi-
ber lesions, then the discharge synchronicity and number
of discharging nerve fibers will be impaired and timing
pattern and magnitude of large scale discharge altered.
Figure 1. Left: Schematic representation of connection
of afferent auditory nerve fibers to an IHC via synapses.
Upper right: Temporal responses of a number of audito-
ry nerve fibers to a stimulation signal. Black arrows -
normal responses; gray arrows - abnormal nerve fiber re-
sponses. Bottom right: Gross auditory nerve response to
the transient stimulus. Abnormal nerve fiber responses
include: a) greatly variable discharge latencies, i.e. poor
synchronicity; and b) reduced number of responding
nerve fibers, i.e. decreased neural discharges [6].
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Particular pathological changes that can potentially dis-
rupt or lower neural conduction synchronicity include
mechanical changes in hair cells, metabolic changes
within hair cells, compromised release and re-uptake of
neurotransmitters, decrease in receptor sensitivity and
impaired discharge initiation at nerve endings, as well as
pathologies involving neurotransmitters, axons and my-
elin sheath.
At this time, the best evidence to support existence of
AN is presence of accompanying peripheral or cranial
nerve neuropathy. If such neuropathy is absent and there
is clear auditory responses to electrical stimulation,
nerve ending-IHC or synaptic lesions are speculated as
the etiology. Synaptic lesions may involve temporal pro-
cessing changes, discharge amplitude changes and affer-
ent nerve receptor changes. In addition, gene mutations
that have been shown to be related to AN through genet-
ic screening need to be further studied to clarify the loca-
tions and pathological mechanisms in AN (see below).
The role of basic research in diagnosis
and treatment of AN
Animal studies at cellular and molecular levels may
provide directions for description and detection of AN le-
sion sites and for development of treatments.
Animal models with known lesion locations at the
IHC and synapses include: 1) Cav1.3 ion channel knock-
out mice [36, 37], in which neurotransmitter release from
IHCs is blocked, with 90% decrease in Ca2 + current [38],
absent ABRs, but preserved high frequency DPOAEs; 2)
Bassoon protein (a structural protein responsible for lo-
cating ribbon synapse to IHC active pre-synaptic area)
mutation mice, in which numbers of synapses and synap-
tic release vesicles are reduced [39], with slightly de-
creased Ca2 + current, abnormal ABRs, but normal CM
and DPOAEs; and 3) OTOF gene (coding the otoferlin
protein which is closely related to the release of ribbon
synaptic vesicles [40]) knockout mice, in which the ribbon
synapse morphology and Ca2 + current are both normal,
but IHC neurotransmitter release is decreased with ab-
sent ABRs but normal OAEs or CM.
Animal models with known lesion locations at the syn-
apse or auditory nerve include: 1) Beta-4 (a protein play-
ing an important role in locating and linking the volt-
age-gated sodium and potassium channels at the node of
Ranvier [41]) gene mutation mice, in which only Wave I
can be induced in some animals with progressive latency
delay; 2) myelin sheath protein gene (PMP22) defect ani-
mals, in which ABR waves show low amplitudes and de-
layed latencies and abnormal myelin sheath formation
and progressive loss of spiral ganglion [42]; and 3) erbB
sensor defect animals, in which ABRs are absent or
grossly abnormal while OAEs are present. Auditory
pathway dysfunction related to this gene involves only
loss of the spiral ganglion, with no peripheral or cranial
nerve neuropathy.
These animal models have served to guide clinical
treatment for AN, i.e. cochlear implant can be expected
to produce good results in patients with presentations
corresponding to animal models of IHC and synaptic le-
sions, whereas it usually fails in those with presentations
corresponding to models of auditory nerve or central au-
ditory pathway damages.
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